Dixon Hughes Goodman Wealth Advisors’s Kyntra Bio KYNB Stock Holding History

Dixon Hughes Goodman Wealth Advisors’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$59K	Buy	+196	New	+$68.3K	0.02%	295

Other funds holding KYNB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Dixon Hughes Goodman Wealth Advisors's KYNB Position: Q1 2022 in Review

Dixon Hughes Goodman Wealth Advisors opened a new position in Kyntra Bio (KYNB) in Q1 2022: 196 shares worth $59K. The stake represents 0.02% of the portfolio and ranks #295 among its holdings.

156 funds tracked by Wall St. Rank hold KYNB as of Q1 2022.

Dixon Hughes Goodman Wealth Advisors held 196 shares of Kyntra Bio worth $59K as of Q1 2022.
Kyntra Bio was a new Dixon Hughes Goodman Wealth Advisors position in Q1 2022.
Kyntra Bio made up 0.02% of Dixon Hughes Goodman Wealth Advisors's portfolio in Q1 2022, its #295 holding.
156 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2022.

Based on Dixon Hughes Goodman Wealth Advisors's 13F filing for Q1 2022, filed 4 Apr 2022.